180 related articles for article (PubMed ID: 17307613)
1. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].
Harper RP; Fung E
J Oral Maxillofac Surg; 2007 Mar; 65(3):573-80. PubMed ID: 17307613
[No Abstract] [Full Text] [Related]
2. Sore mandible. Bisphosphonate-associated osteonecrosis.
Damm DD; Fantasia JE
Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
[No Abstract] [Full Text] [Related]
3. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
[No Abstract] [Full Text] [Related]
4. Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case.
Senel FC; Saracoglu Tekin U; Durmus A; Bagis B
J Oral Maxillofac Surg; 2007 Mar; 65(3):562-5. PubMed ID: 17307610
[No Abstract] [Full Text] [Related]
5. Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene.
Vairaktaris E; Vassiliou S; Avgoustidis D; Stathopoulos P; Toyoshima T; Yapijakis C
J Oral Maxillofac Surg; 2009 Sep; 67(9):2009-12. PubMed ID: 19686941
[No Abstract] [Full Text] [Related]
6. Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws.
Vescovi P; Manfredi M; Merigo E; Meleti M
J Oral Maxillofac Surg; 2008 Apr; 66(4):831-2. PubMed ID: 18355616
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.
Narongroeknawin P; Danila MI; Humphreys LG; Barasch A; Curtis JR
Spec Care Dentist; 2010; 30(2):77-82. PubMed ID: 20415805
[TBL] [Abstract][Full Text] [Related]
8. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
[No Abstract] [Full Text] [Related]
9. Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw.
Wilde F; Hendricks J; Riese C; Pausch NC; Schramm A; Heufelder M
J Oral Maxillofac Surg; 2011 Oct; 69(10):2657-62. PubMed ID: 21741741
[No Abstract] [Full Text] [Related]
10. Osteonecrosis associated with short-term oral administration of bisphosphonate.
Takagi Y; Sumi Y; Harada A
J Prosthet Dent; 2009 May; 101(5):289-92. PubMed ID: 19410063
[TBL] [Abstract][Full Text] [Related]
11. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Gallego L; Junquera L
Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate treatment as a cause of jaw osteonecrosis.
Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
[No Abstract] [Full Text] [Related]
13. Bisphosphonate osteonecrosis: a protocol for surgical management.
Markose G; Mackenzie FR; Currie WJ; Hislop WS
Br J Oral Maxillofac Surg; 2009 Jun; 47(4):294-7. PubMed ID: 19231046
[TBL] [Abstract][Full Text] [Related]
14. Images in clinical medicine. Halitosis and sensory loss.
Scully C; Brooke AE
N Engl J Med; 2012 Aug; 367(6):551. PubMed ID: 22873535
[No Abstract] [Full Text] [Related]
15. By the way, doctor. I'm 60 and have osteoporosis. My doctor is recommending Fosamax, but I'm concerned about jawbone problems. Are there any other drugs I can take?
Robb-Nicholson C
Harv Womens Health Watch; 2006 Dec; 14(4):8. PubMed ID: 17299880
[No Abstract] [Full Text] [Related]
16. Prosthodontic treatment during active osteonecrosis related to radiation and bisphosphonate therapy: a clinical report.
Marunick M; Gordon S
J Prosthet Dent; 2006 Jul; 96(1):7-12. PubMed ID: 16872925
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-Related Osteonecrosis of the Jaw After Tooth Extraction.
Ribeiro NR; Silva Lde F; Santana DM; Nogueira RL
J Craniofac Surg; 2015 Oct; 26(7):e606-8. PubMed ID: 26468839
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
Yamaguchi K; Oizumi T; Funayama H; Kawamura H; Sugawara S; Endo Y
J Oral Maxillofac Surg; 2010 Apr; 68(4):889-97. PubMed ID: 20056305
[No Abstract] [Full Text] [Related]
19. Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?
Wynn RL
Gen Dent; 2007; 55(6):495-8. PubMed ID: 18050572
[No Abstract] [Full Text] [Related]
20. The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw.
Otto S; Hafner S; Grötz KA
J Oral Maxillofac Surg; 2009 Mar; 67(3):589-92. PubMed ID: 19231785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
